[144] Veritex Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Veritex Holdings, Inc. (VBTX) discloses a proposed sale of 2,527 common shares through Charles Schwab, planned on 09/02/2025 on Nasdaq with an aggregate market value of $86,588.00. The filer reports acquiring 2,500 shares on 03/12/2021 via a private purchase from the issuer paid in cash and an additional 27 shares on 12/11/2023 via dividend reinvestment paid in cash. There are 54,745,471 shares outstanding per the form and no securities sold by the filer in the past three months. The filing includes the required representation that the seller has no undisclosed material adverse information.

Positive

• Complete disclosure of planned sale details: broker, sale date, quantity, and aggregate market value.
• Acquisition history provided with dates and payment method for all shares to be sold.
• No sales in past three months reported, simplifying aggregation rules under Rule 144.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 disclosure of a small planned sale; no recent disposals reported.

The filing describes a proposed sale of 2,527 common shares of Veritex via Charles Schwab on Nasdaq with an aggregate value of $86,588.00. Acquisition history is documented (private purchase in 2021 and dividend reinvestment in 2023) and payment was in cash. There are no reported sales in the past three months and the filer affirms no undisclosed material adverse information. As presented, this is a standard compliance disclosure rather than a material corporate event.

Compliance/Risk Analyst

TL;DR: Disclosure meets Rule 144 content requirements; includes broker, dates, quantities, and acquisition details.

The form includes required broker identification, exact share counts, acquisition dates and methods, and the seller's certification regarding material adverse information. The absence of recent sales is noted. From a compliance standpoint the notice contains the elements regulators expect for a proposed sale under Rule 144; it does not indicate regulatory or disclosure risk based on the information provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	2527	86588.00	54745471	09/02/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/12/2021	Private Purchase before bank went public	Issuer			2500	03/12/2021	Cash
Common	12/11/2023	Dividend Reinvestment	Issuer			27	12/11/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Veritex Holdings (VBTX) disclose?

It discloses a proposed sale of 2,527 common shares via Charles Schwab on 09/02/2025 with an aggregate market value of $86,588.00.

How many Veritex shares were acquired and when?

The filer acquired 2,500 shares on 03/12/2021 by private purchase from the issuer and 27 shares on 12/11/2023 via dividend reinvestment.

Are there any reported sales by the filer in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

What exchange will the sale occur on and how many shares are outstanding?

The sale is planned on Nasdaq and the filing lists 54,745,471 shares outstanding.

Does the filer assert any undisclosed material information about Veritex?

No. By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.